ETV2 and myocardial ischemia: EC–VSMC interactions affect VSMC turnover and regulate the function of VSMCs [1,22]; several reports have confirmed that ETV2 can induce the maturation of ECs, promote vascular development, and be used as a therapeutic agent in myocardial ischemia [20,23,24].